Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Natural History of Post-transfusion Non-A, Non-B Hepatitis

This study has been completed.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI) Identifier:
First received: May 25, 2000
Last updated: April 13, 2016
Last verified: August 2004
To compare the clinical, biochemical, and histological status of Non-A, Non-B post-transfusion hepatitis patients with that of patients who did not develop post-transfusion hepatitis.

Hepatitis, Viral, Human
Blood Transfusion
Liver Diseases

Study Type: Observational

Resource links provided by NLM:

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: March 1988
Estimated Study Completion Date: September 2001
  Show Detailed Description


Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00005306

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
OverallOfficial: Leonard Seeff Georgetown University
  More Information

Publications: Identifier: NCT00005306     History of Changes
Other Study ID Numbers: 3007 
Study First Received: May 25, 2000
Last Updated: April 13, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Hepatitis A
Liver Diseases
Hepatitis, Viral, Human
Digestive System Diseases
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections processed this record on October 27, 2016